DK1438307T3 - Derivater af 4-(thio- eller selenoxanthen-9-yliden)-piperidin eller acridin og anvendelse heraf som selektive 5-HT2Breceptor-antagonister - Google Patents

Derivater af 4-(thio- eller selenoxanthen-9-yliden)-piperidin eller acridin og anvendelse heraf som selektive 5-HT2Breceptor-antagonister

Info

Publication number
DK1438307T3
DK1438307T3 DK02785280T DK02785280T DK1438307T3 DK 1438307 T3 DK1438307 T3 DK 1438307T3 DK 02785280 T DK02785280 T DK 02785280T DK 02785280 T DK02785280 T DK 02785280T DK 1438307 T3 DK1438307 T3 DK 1438307T3
Authority
DK
Denmark
Prior art keywords
ylidene
acridine
thio
piperidine
derivatives
Prior art date
Application number
DK02785280T
Other languages
English (en)
Inventor
Hermann Luebbert
Emile Bellott
Mark Froimowitz
Christoph Ullmer
Douglas Gordon
Original Assignee
Biofrontera Pharmaceuticals Gm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofrontera Pharmaceuticals Gm filed Critical Biofrontera Pharmaceuticals Gm
Application granted granted Critical
Publication of DK1438307T3 publication Critical patent/DK1438307T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D421/00Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D421/02Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings
    • C07D421/04Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK02785280T 2001-10-25 2002-10-23 Derivater af 4-(thio- eller selenoxanthen-9-yliden)-piperidin eller acridin og anvendelse heraf som selektive 5-HT2Breceptor-antagonister DK1438307T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01125527A EP1306376A1 (en) 2001-10-25 2001-10-25 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist

Publications (1)

Publication Number Publication Date
DK1438307T3 true DK1438307T3 (da) 2005-12-12

Family

ID=8179078

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02785280T DK1438307T3 (da) 2001-10-25 2002-10-23 Derivater af 4-(thio- eller selenoxanthen-9-yliden)-piperidin eller acridin og anvendelse heraf som selektive 5-HT2Breceptor-antagonister

Country Status (14)

Country Link
EP (2) EP1306376A1 (da)
JP (1) JP4452501B2 (da)
KR (1) KR100921214B1 (da)
CN (1) CN100345843C (da)
AT (1) ATE301119T1 (da)
AU (1) AU2002350603B2 (da)
CA (1) CA2462416C (da)
DE (1) DE60205397T2 (da)
DK (1) DK1438307T3 (da)
ES (1) ES2246416T3 (da)
HK (1) HK1073311A1 (da)
RU (1) RU2314305C2 (da)
WO (1) WO2003035646A2 (da)
ZA (1) ZA200403095B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1616192A1 (en) * 2002-12-23 2006-01-18 Bayer HealthCare AG Diagnostics and therapeutics for diseases assosciated with 5-hydroxytryptamine (serotonin) receptor 2b (5-hteb)
EA015491B1 (ru) * 2003-06-27 2011-08-30 Янссен Фармацевтика Н.В. ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ
EP1910353A1 (en) 2004-08-05 2008-04-16 Janssen Pharmaceutica N.V. Tricyclic delta- opioid modulators
CN101115751A (zh) 2004-12-22 2008-01-30 詹森药业有限公司 三环δ-阿片样物质调节剂
CN101119992A (zh) 2004-12-22 2008-02-06 詹森药业有限公司 三环δ阿片样物质调节剂
CA2594347A1 (en) 2005-01-06 2006-07-13 Janssen Pharmaceutica N.V. Tricyclic d-opioid modulators
TW200716134A (en) 2005-06-16 2007-05-01 Janssen Pharmaceutica Nv Tricyclic opioid modulators
WO2008124184A1 (en) * 2007-04-09 2008-10-16 Xvasive Inc. Treatment of headaches, neck pain, joint pain and inflammatory-type pain
WO2014117863A1 (en) * 2013-02-01 2014-08-07 Biofrontera Bioscience Gmbh Salt polymorph of thioxanthene - 9 - ylidene - 1 - methyl piperidine acid addition salts as antimigraine compounds
KR102105682B1 (ko) 2018-08-29 2020-04-28 성균관대학교산학협력단 신규 2-아실 아크리딘 유도체, 이의 제조방법, 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122808C (da) * 1961-09-29
NL301204A (da) * 1962-12-07
NL6818027A (da) * 1968-01-09 1969-07-11
BE791699A (fr) * 1971-11-22 1973-05-21 Sandoz Sa Nouveaux derives du thioxanthene, leur preparation et leur application comme medicaments
ZA756550B (en) * 1974-11-06 1976-09-29 Smithkline Corp Pharmaceutical compositions and method of producing antipsychotic activity without extrapyramidal symptoms
US4086350A (en) * 1974-11-06 1978-04-25 Smithkline Corporation Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
US4285956A (en) * 1978-05-12 1981-08-25 Kefalas A/S Xanthene and thioxanthene derivatives, compositions thereof and treatment therewith
US4777177A (en) * 1984-10-19 1988-10-11 Ciba-Geigy Corporation Pesticidal thioxanthen-9-ylidenepiperidines

Also Published As

Publication number Publication date
CN1575291A (zh) 2005-02-02
CN100345843C (zh) 2007-10-31
ATE301119T1 (de) 2005-08-15
AU2002350603B2 (en) 2008-02-28
EP1306376A1 (en) 2003-05-02
WO2003035646A2 (en) 2003-05-01
CA2462416C (en) 2011-04-26
EP1438307B1 (en) 2005-08-03
JP4452501B2 (ja) 2010-04-21
RU2314305C2 (ru) 2008-01-10
ES2246416T3 (es) 2006-02-16
CA2462416A1 (en) 2003-05-01
DE60205397D1 (de) 2005-09-08
DE60205397T2 (de) 2006-05-24
EP1438307A2 (en) 2004-07-21
KR20040047982A (ko) 2004-06-05
RU2004116070A (ru) 2005-11-10
ZA200403095B (en) 2005-01-25
WO2003035646A3 (en) 2003-09-04
JP2005510504A (ja) 2005-04-21
HK1073311A1 (en) 2005-09-30
KR100921214B1 (ko) 2009-10-09

Similar Documents

Publication Publication Date Title
NO20060195L (no) Kinolylamidderivater som CCR-5-antagonister
HK1073311A1 (en) Derivatives of 4-(thioxanthene-9-ylidene)-piperid ine or acridine and its use in the manufacture of a medicament
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
TW200635897A (en) Piperidine derivatives and their use as anti-inflammatory agents
NO20054220L (no) Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
NO20062713L (no) 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister
ATE377589T1 (de) 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
AR061486A1 (es) Derivados de 2-pirazinacarboxamida
NO20050164L (no) Nye quinuklidin-amid-derivater
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
WO2006007540A3 (en) Piperidine derivatives as nk1 antagonists
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
NO20081970L (no) Sulfonamidderivat med PGD2-reseptorantagonistaktivitet
EA200801909A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
NO20045486L (no) Nye forbindelser og deres anvendelse
NO20062491L (no) Benzoksazinderivter og deres anvendelse
AR056883A1 (es) Derivados de 7-azaindol-2 carboxamida, un proceso para la preparacion de los mismos, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades asociadas con la modulacion de receptores de h3
HUP0402019A2 (hu) CCR5 antagonistaként alkalmazható piperidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
DK1611144T3 (da) Derivater af 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl-phosphonsyre og deres avendelse som n-methyl-D-aspartat (NMDA)-receptor-antagonister
ATE418548T1 (de) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
NO20075022L (no) (7-(2-(4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyrid-1-yl)etyl) isokinolinbesylatsalt, fremstilling og terapeutiske anvendelser derav
WO2007143523A3 (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
HK1097474A1 (en) Carbostyril derivatives for accelerating salivation